Literature DB >> 2415009

What participants understand about a maternal serum alpha-fetoprotein screening program.

R R Faden, A J Chwalow, E Orel-Crosby, N A Holtzman, G A Chase, C O Leonard.   

Abstract

We investigated the knowledge of pregnant women participating in a maternal serum alphafetoprotein (MSAFP) screening program for the detection of neural tube defects (NTDs) in the fetus. Women participating in the screening program scored higher on two knowledge tests than a comparison group of pregnant women who were not offered screening. However, there were substantial gaps in the knowledge base of women in the program, as measured by one of the tests. Women did not misinterpret a negative test result to mean that the test had identified a potential problem with the fetus; instead, there is a suggestion that they tended to interpret a negative result too positively, as an assurance that the baby was healthy in all respects.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh:

Substances:

Year:  1985        PMID: 2415009      PMCID: PMC1646434          DOI: 10.2105/ajph.75.12.1381

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Pregnancy planning guide. Evidence-based information for prospective parents.

Authors:  Krista M Maier; Colleen M Kirkham; Elizabeth Lim; Ka Wai Cheung; Stefan Grzybowski
Journal:  Can Fam Physician       Date:  2002-07       Impact factor: 3.275

2.  Maternal serum AFP: educating physicians and the public.

Authors:  G J Annas; S Elias
Journal:  Am J Public Health       Date:  1985-12       Impact factor: 9.308

3.  AFP anxiety.

Authors:  P C Stillman; J K Hoffman
Journal:  West J Med       Date:  1986-09

4.  The California Alpha-Fetoprotein Screening Program defended.

Authors:  G C Cunningham
Journal:  West J Med       Date:  1987-07

5.  Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.

Authors:  M E Mennie; W A Liston; D J Brock
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

6.  Update and Review: Maternal Serum Screening.

Authors:  K E Ormond
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

7.  Distress associated with prenatal screening for fetal abnormality.

Authors:  Marci Lobel; Lynette Dias; Bruce A Meyer
Journal:  J Behav Med       Date:  2005-02

8.  Pre-screening education in multiple marker screening programs: The effect on patient anxiety and knowledge.

Authors:  K E Ormond; E Pergament; B A Fine
Journal:  J Genet Couns       Date:  1996-06       Impact factor: 2.537

9.  Prenatal screening and pregnant women's attitudes toward the abortion of defective fetuses.

Authors:  R R Faden; A J Chwalow; K Quaid; G A Chase; C Lopes; C O Leonard; N A Holtzman
Journal:  Am J Public Health       Date:  1987-03       Impact factor: 9.308

10.  The role of numeracy on client knowledge in BRCA genetic counseling.

Authors:  David B Portnoy; Debra Roter; Lori H Erby
Journal:  Patient Educ Couns       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.